상피성 난소암에서 HER-2/neu 단백 발현

키워드

참고문헌 (25)

1. Bishop JM, "Molecular themes in oncogenesis", 64, pp.235~48 (1991)
2. Berek AS, "Practical gynecologic oncology", pp.453~454 (2005), Lippincott Williams & Wilkins
3. Wu Y, "Her-2", neu expression and amplification in early stage ovarian surface epithelial neoplasms, 2004, pp.95, 570~575
4. Slamon DJ, "Human breast cancer:correlation of relapse and survival with amplification of the HER-2", neu oncogene, 1987, pp.235, 177~82
5. Gusterson BA, "Prognostic improtance of c-erbB-2 expression in breast cancer", pp.1049~56
6. Emens LA, "Trastuzumab: targeted therapy for the management of HER-2", neu-overexpressing metastatic breast cancer, 2005, pp.12(3), 243~253
7. 대한산부인과학회 부인종양학회, "한국 부인암 등록 사업 조사 보고서", 48, pp.1130~1180 (2005), 대한산부인과학회 부인종양학회
8. Bookman MA, "Evaluation of monoclonal humanized anti-HER2 antibody in patients With recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2 a phase II trial of the Gynecologic Oncology Group", 21, pp.283~290 (2003)
9. Hellstrom I, "Overexpression of HER-2 in ovarian carcinomas", 61, pp.2420~2423 (2001)
10. McKenzie SJ, "Serum levels of HER-2 neu correlate with overexpression of p185neu in human ovarian cancer", pp.3942~6
11. Berchuck A, "Human ovarian cancer of the surface epithelium", 54(5), pp.541~544 (1997)
12. Cirisano FD, "The role of the HER-2", neu oncogene in gynecologic cancers, 1996, pp.3, 99~105
13. Hogdall EV, "Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma:from the Danish MALOVA Ovarian Cancer Study", 98, pp.66~73 (2003)
14. Tanabe H, "Overexpression of HER-2", neu is not a risk factor in ovarian clear cell adenocarcinoma, 2004, pp.94, 735~739
15. Padhy LC, "Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas", 28(4), pp.865~71 (1982)
16. Hynes NE, "The biology of erbB-2", neu, pp.1994, 1198[DOI]
17. Lupu R, "Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance", 6, pp.135~145 (1995)
18. Clark GM, "Amplification of c-erbB-2 and aggressive human breast tumors? Science 1988", pp.1795~8
19. Hung MC, "Basic science of HER-2", neu:a review, 1999, pp.26, 51~59
20. King CR, "Amplification of a novel v-erbB- related gene in a human mammary carcinoma", 229, pp.974~6 (1985)
21. Clark GM, "Follow-up study of HER-2", neu amplification in primary breast cancer, 1991, pp.51, 944~8
22. Slamon DJ, "Studies of the HER-2", neu proto-oncogene in human breast and ovarian cancer, 1989, pp.244, 707~12
23. Felip E, "Overexpression of c-erbB-2 in epithelial ovarian cancer Prognostic value and relationship with response to chemotherapy", 75, pp.2147~2152 (1995)
24. Berchuck A, "Overexpression of HER-2", neu is associated with poor survival in advanced epithelial ovarian cancer, 1990, pp.50, 4087~91
25. Rubin SC, "Prognostic significance of HER-2", neu expression in advanced epithelial ovarian cancer:a multivariate analysis, 1993, pp.168, 162~9

관련 논문AI추천